Semaglutide is a glp-1 or glucagon-like peptide (known as Ozempic)
Most reported headaches are mild to moderate in intensity and resolve spontaneously without requiring treatment discontinuation
It also enhances metabolism, optimizing the body's calorie-burning efficiency
J., Rivera-Mirabal, J., Yu, J., Kovac, J., Pastuszak, A
However, if skipping becomes a pattern, the cumulative effect of repeated dose gaps can slow your overall weight loss velocity and reduce your treatment efficiency over months
I wont delve into the details of the options available in this article, but briefly: Wegovy (semaglutide) and Zepbound (tirzepatide) are approved by the Food and Drug Administration (FDA) for weight loss, and Mounjaro (tirzepatide) and Ozempic (semaglutide) are approved for helping with type 2 diabetes